Futura Medical Share News (FUM)

Futura Medical hails results as erectile dysfunction drug drives sales

(Alliance News) - Futura Medical PLC on Wednesday celebrated its "first set out meaningful revenues" in 2023, as sales for its erectile dysfunction treatment climbed.

UK earnings, trading statements calendar - next 7 days

IN BRIEF: Futura Medical's Eroxon to soon be available on prescription

Futura Medical PLC - Guildford, England-based pharmaceutical company focused on sexual health products - Confirms that lead product Eroxon will from March 1 be available on prescription in England and Wales for the treatment of erectile dysfunction. Eroxon is a gel-based treatment designed to help the user obtain an erection, and serves as an alternative for people who are unwilling or unable to use medications like Viagra. Eroxon has also been available without a prescription in UK pharmacies since March last year.

LONDON MARKET CLOSE: BP and Prudential help snap FTSE losing streak

(Alliance News) - Stock prices in London pushed higher on Tuesday, with the FTSE 100 registering its first rise in four trading days, with oil major BP the star performer.

Futura Medical shares surge after "transformational year"

(Alliance News) - Futura Medical PLC on Tuesday reported its first revenues in 2023, thanks to the successful global roll-out of Eroxon.

Futura has 'transformational year' in 2023

(Sharecast News) - Consumer healthcare company Futura said on Tuesday that 2023 had been a "transformational year", with the group generating its first meaningful revenues and laying the foundations for "significant growth acceleration".

Futura Medical extends agreement with Cooper Consumer Health

(Sharecast News) - Sexual health product developer Futura Medical announced an extension of its exclusive licensing agreement with Cooper Consumer Health on Monday.

Futura Medical extends licensing deal for erectile dysfunction gel

(Alliance News) - Futura Medical PLC on Monday said that it has extended its exclusive licensing agreement with Cooper Consumer Health Group, a European self-care organisation, to January 2029.

TRADING: Zambeef sees profit above market views; Luceco trades in line

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Futura Medical gets Mexico marketing authorisation for Eroxon gel

(Alliance News) - Futura Medical PLC on Wednesday said the Mexican Secretariat of Health has granted over the counter sale marketing authorisation for its erectile dysfunction topical gel formulation Eroxon.

IN BRIEF: Futura Medical launches erectile dysfunction gel in UAE

Futura Medical PLC - Guildford, Surrey-based pharmaceutical company - Says that it has launched Exoron in the United Arab Emirates. Exoron, or MED3000, is a topical gel used to treat erectile dysfunction. It uses Futura's proprietary technology, DermaSys. The product is now available for purchase online through the BinSina Pharmacy in the UAE, the first market in the Middle East to stock the product.

Futura Medical wis European patent for erectile dysfunction gel

(Sharecast News) - Sexual health specialist Futura Medical announced the successful acquisition of an EU patent for its MED3000 topical erectile dysfunction product on Monday.

IN BRIEF: Futura Medical granted European patent for ED treatment

Futura Medical PLC - Guildford, Surrey-based pharmaceutical company - Receives European patent for erectile dysfunction treatment, MED3000, until 2040. Continues to pursue patent applications to provide wider patent protection. Chief Executive Officer James Barder says: "The allowance of this patent application further cements the intellectual property of MED3000, as we support our distributors' roll out of our fast acting topically applied gel for the treatment of erectile dysfunction available without a doctor's prescription across the world."

TRADING UPDATES: Elixirr record half-year revenue; Bango profit down

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

UK earnings, trading statements calendar - next 7 days